232 related articles for article (PubMed ID: 28777690)
1. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
Fakhry C; Zhang Q; Nguyen-Tân PF; Rosenthal DI; Weber RS; Lambert L; Trotti AM; Barrett WL; Thorstad WL; Jones CU; Yom SS; Wong SJ; Ridge JA; Rao SSD; Bonner JA; Vigneault E; Raben D; Kudrimoti MR; Harris J; Le QT; Gillison ML
J Clin Oncol; 2017 Dec; 35(36):4057-4065. PubMed ID: 28777690
[TBL] [Abstract][Full Text] [Related]
2. Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database.
Nelson TJ; Thompson CA; Zou J; Kumar A; Sangchan P; Williamson CW; Vitzthum LK; Sharabi AB; Murphy JD; Fakhry CA; Mell LK
Cancer; 2022 May; 128(10):1948-1957. PubMed ID: 35194791
[TBL] [Abstract][Full Text] [Related]
3. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
Fakhry C; Zhang Q; Gillison ML; Nguyen-Tân PF; Rosenthal DI; Weber RS; Lambert L; Trotti AM; Barrett WL; Thorstad WL; Yom SS; Wong SJ; Ridge JA; Rao SSD; Spencer S; Fortin A; Raben D; Harris J; Le QT
Cancer; 2019 Jun; 125(12):2027-2038. PubMed ID: 30913305
[TBL] [Abstract][Full Text] [Related]
4. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
[TBL] [Abstract][Full Text] [Related]
5. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
6. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
[TBL] [Abstract][Full Text] [Related]
7. Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma.
Gorphe P; Chekkoury Idrissi Y; Tao Y; Moya-Plana A; Casiraghi O; Janot F; Blanchard P; Mirghani H; Temam S
Head Neck; 2019 Apr; 41(4):1039-1045. PubMed ID: 30552841
[TBL] [Abstract][Full Text] [Related]
8. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
9. Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).
Grønhøj C; Jensen DH; Dehlendorff C; Marklund L; Wagner S; Mehanna H; Munck-Wikland E; Ramqvist T; Näsman A; Wittekindt C; Würdemann N; Sharma SJ; Gattenlöhner S; Kiss K; Andersen E; Spruce R; Batis N; Robinson M; Harrington K; Winter S; Jones TM; Klussmann JP; Dalianis T; Friborg J; von Buchwald C
Br J Cancer; 2018 Jun; 118(12):1672-1681. PubMed ID: 29795309
[TBL] [Abstract][Full Text] [Related]
10. Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients.
Larsen CG; Jensen DH; Carlander AF; Kiss K; Andersen L; Olsen CH; Andersen E; Garnæs E; Cilius F; Specht L; von Buchwald C
Oncotarget; 2016 Nov; 7(44):71761-71772. PubMed ID: 27708214
[TBL] [Abstract][Full Text] [Related]
11. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy.
Zhu X; Liu W; Cao Y; Su T; Zhu X; Wang Y; Ju X; Zhao X; Jiang L; Ye Y; Zhang H
Front Oncol; 2021; 11():688576. PubMed ID: 34169000
[TBL] [Abstract][Full Text] [Related]
13. Applying nomograms based on the surveillance, epidemiology and end results database to predict long-term overall survival and cancer-specific survival in patients with oropharyngeal squamous cell carcinomas: A case-control research.
Wang F; Wen J; Yang X; Jia T; Du F; Wei J
Medicine (Baltimore); 2020 Jul; 99(30):e20703. PubMed ID: 32791664
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
Lassen P; Lacas B; Pignon JP; Trotti A; Zackrisson B; Zhang Q; Overgaard J; Blanchard P;
Radiother Oncol; 2018 Jan; 126(1):107-115. PubMed ID: 29100700
[TBL] [Abstract][Full Text] [Related]
15. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
16. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.
Gillison ML; Zhang Q; Jordan R; Xiao W; Westra WH; Trotti A; Spencer S; Harris J; Chung CH; Ang KK
J Clin Oncol; 2012 Jun; 30(17):2102-11. PubMed ID: 22565003
[TBL] [Abstract][Full Text] [Related]
17. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.
Fakhry C; Zhang Q; Nguyen-Tan PF; Rosenthal D; El-Naggar A; Garden AS; Soulieres D; Trotti A; Avizonis V; Ridge JA; Harris J; Le QT; Gillison M
J Clin Oncol; 2014 Oct; 32(30):3365-73. PubMed ID: 24958820
[TBL] [Abstract][Full Text] [Related]
19. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
[TBL] [Abstract][Full Text] [Related]
20. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
